Position in AMGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$429,112
-$1,937,079 QoQ
Shares Held
1,185
-82.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#2,281
of 3,140 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ATLAS CAPITAL ADVISORS INC. holds $9,612,551 across 15 Drug Manufacturers - General names. AMGN ranks #7 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,869 | $4,640,595 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
7,901 | $998,212 | |
| 3 | MRK |
Merck & Co., Inc.
|
5,216 | $670,256 | |
| 4 | BIIB |
Biogen Inc.
|
2,930 | $633,055 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
10,844 | $624,831 | |
| 6 | AZN |
Astrazeneca PLC
|
2,976 | $564,309 | |
| 7 | AMGN |
Amgen Inc
This page
|
1,185 | $429,112 | |
| 8 | GRFS |
Grifols SA
|
31,637 | $223,989 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $429,112 | 1,185 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,366,191 | 6,725 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $2,201,159 | 6,725 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $1,876,570 | 6,721 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,103,585 | 6,752 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,759,841 | 6,752 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $391,485 | 1,215 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $2,084,041 | 6,670 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $392,645 | 1,381 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $1,988,778 | 6,905 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $1,855,787 | 6,905 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,510,846 | 6,805 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $1,648,251 | 6,818 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $1,794,356 | 6,832 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $1,597,184 | 7,086 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,720,860 | 7,073 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $1,718,614 | 7,107 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $1,581,089 | 7,028 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $1,547,666 | 7,278 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $1,847,137 | 7,578 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $1,877,769 | 7,547 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $1,677,726 | 7,297 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,854,605 | 7,297 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $1,789,469 | 7,587 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $1,549,870 | 7,645 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||